BioSpace News Archive

Vera Therapeutics, Inc. announced that the Company’s management team will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, taking place June 10 – 13, 2024 at the Loews Miami Beach Hotel, Miami Beach, FL.

Vera Therapeutics, Inc. announced that on June 4, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 31,250 shares of Class A common stock and restricted stock units for 14,500 shares of Class A common stock to five new employees under Vera’s 2024 Inducement Plan.

Structure Therapeutics Inc. announced the closing of its previously announced upsized underwritten public offering of 10,427,017 American depositary shares, each representing three ordinary shares, including the full exercise of the underwriters’ option to purchase up to 1,360,045 additional ADSs, at a public offering price of $52.50 per ADS.

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, reported the grant of 9,700 restricted stock units of Atara’s common stock to one newly hired employee.

ORIC Pharmaceuticals, Inc. announced that on June 3, 2024, ORIC granted a total of 30,000 non-qualified stock options and 4,800 restricted stock units to three new non-executive employees who began their employment with ORIC in May 2024.

Incyte announced that it granted restricted stock unit awards representing an aggregate of 14,090 shares of the Company’s common stock and stock option awards to purchase an aggregate of 9,238 shares of the Company’s common stock to 17 new employees.

Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”), today announced that it is undertaking a private placement of unsecured debenture units.

3Shape announces the launch of three exciting solutions at its 3Shape Discover digital dentistry event.

BrainTale, a medtech deciphering white matter to enable better brain care, spin-off of the Paris Region Greater Hospitals, presented the results of the “Cerebral diffusion tensor imaging in patients with liver diseases admitted for evaluation of neurological symptoms” study led by Professor Nicolas Weiss, during the European Association for the Study of Liver congress in Milan from June 05 to 08, 2024.

Senzime AB announced that it has secured a purchasing contract with the number one ranked children’s hospital system in the United States for its TetraGraph® quantitative neuromuscular monitoring system.